Core Viewpoint - Vistagen Therapeutics is facing a federal securities class action lawsuit due to allegations of making false and misleading statements regarding the efficacy of its drug fasedienol, leading to significant financial losses for investors [1][1]. Group 1: Legal Proceedings - Faruqi & Faruqi, LLP is investigating potential claims against Vistagen Therapeutics and has set a deadline of March 16, 2026, for investors to seek the role of lead plaintiff in the class action [1]. - The lawsuit claims that Vistagen and its executives violated federal securities laws by failing to disclose material adverse facts about the drug fasedienol's trial results [1][1]. - Following the announcement of the failed PALISADE-3 clinical trial results, Vistagen's stock price plummeted over 81%, opening at $0.88 per share [1][1]. Group 2: Clinical Trial Results - On December 17, 2025, Vistagen reported that its PALISADE-3 study did not meet its primary efficacy endpoint, failing to show statistically significant improvement in reducing anxiety compared to placebo [1][1]. - The positive assertions made by Vistagen regarding fasedienol's future trial success were deemed false and misleading, contributing to the inflated stock prices prior to the announcement [1][1]. Group 3: Investor Information - Investors who purchased Vistagen securities between April 1, 2024, and December 16, 2025, are encouraged to contact Faruqi & Faruqi for discussions regarding their legal rights [1][1]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Vistagen's conduct [1][1].

Core Insights - PureHealth Research has introduced supplements for lymphatic system support that utilize Dandelion and Burdock Root in a "Flush and Filter" approach to combat unexplained swelling [1] Group 1: Lymphatic System Function - The lymphatic system lacks a central pump and relies on muscle movement and breathing for lymph fluid circulation, leading to potential fluid buildup and a feeling of puffiness when flow slows [1] - Lymphatic congestion can impair immune response as lymph nodes struggle to filter harmful substances effectively when fluid movement is hindered [1] Group 2: Ingredients and Benefits - Dandelion Extract offers gentle diuretic action to reduce excess fluid without depleting potassium levels, making it safer for daily use compared to harsh diuretics [1] - Burdock Root aids in blood purification and supports liver and kidney function during lymphatic drainage, creating a comprehensive flush-and-filter system [1] - The supplements also include additional botanicals like Echinacea and Cleavers to enhance natural drainage pathways and promote healthy fluid balance and immune function [1]

Core Insights - CHAI has achieved a remarkable 3X annual growth rate, reaching $68 million in Annual Recurring Revenue (ARR) and a valuation of $1.4 billion over the past three years [1][1][1] Company Growth - The company has experienced phenomenal momentum, indicating strong market demand and user engagement [1][1] - CHAI's growth trajectory reflects its commitment to providing an engaging platform for users to create and interact with customized chatbots [1][1] AI Safety Measures - CHAI emphasizes the importance of safety in AI, investing significantly in ensuring platform security as it scales [1][1] - The company aligns its safety protocols with global standards, including the EU AI Act and the NIST AI Risk Management Framework [1][1] - A moderation system is in place to filter out harmful content, and an advanced real-time classifier is developed to detect suicidal ideation or self-harm scenarios [1][1] User Support and Transparency - CHAI's AI is designed to respond compassionately to users expressing suicidal or self-harm thoughts, directing them to appropriate human support [1][1] - The platform logs user interactions on secure servers, conducting anonymized reviews to identify risks while maintaining user privacy [1][1] - The company aims to set a precedent for user safety and ethical technology use, collaborating with safety experts to enhance its safety framework [1][1]

Core Viewpoint - Rosen Law Firm is reminding former stockholders of Smartsheet Inc. about a class action lawsuit related to the company's January 2025 sale to a consortium led by Blackstone, Vista Equity Partners, and Platinum Falcon, with a lead plaintiff deadline of February 24, 2026 [1] Group 1: Class Action Details - Former Smartsheet stockholders may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 24, 2026 [1] - The complaint alleges that Smartsheet's solicitation of stockholder approval for the Buyout involved a false and misleading Proxy statement that mischaracterized the company's financial performance [1] Group 2: Allegations Against Defendants - The defendants are accused of intentionally portraying Smartsheet's quarterly earnings negatively and emphasizing a fabricated financial metric to solicit approval for the Buyout [1] - Mark P. Mader, a defendant, is alleged to have failed in his disclosure duties by not exercising reasonable care [1] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for settlements since 2013 [1] - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [1]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Apollo Global Management, Inc. due to allegations of misleading business information [1] Group 1: Investigation Details - The investigation is prompted by an article from Financial Times stating that Apollo executives, including CEO Marc Rowan, discussed tax arrangements with Jeffrey Epstein throughout the 2010s, contradicting previous claims that the firm "never did any business" with Epstein [1] - Following the news, Apollo's stock experienced a decline of 1% on February 2, 2026, and a further drop of 4.76% on February 3, 2026 [1] Group 2: Class Action Information - Investors who purchased Apollo securities may be entitled to compensation through a contingency fee arrangement, allowing them to join the class action without upfront costs [1] - Interested investors can join the prospective class action by visiting the provided link or contacting Rosen Law Firm directly [1] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [1] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [1]

Core Viewpoint - Enphase Energy, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its financial and operational prospects, particularly related to inventory management and the impact of the expiration of the Residential Clean Energy Credit [1] Summary by Relevant Sections Class Action Lawsuit Details - The class action lawsuit is titled Tripathi v. Enphase Energy, Inc., and covers the period from April 22, 2025, to October 28, 2025 [1] - Investors who suffered substantial losses during this period have until April 20, 2026, to seek appointment as lead plaintiff [1] Allegations Against Enphase Energy - The lawsuit alleges that Enphase Energy overstated its ability to manage channel inventory and mitigate the effects of the termination of the Residential Clean Energy Credit [1] - It is claimed that these misrepresentations led to an overstatement of the company's financial and operational prospects [1] - Following the disclosure of financial results on October 28, 2025, Enphase Energy's stock price fell by more than 15% due to expected lower battery storage shipments and revenue impacts from the expiration of the 25D Credit [1] Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Enphase Energy securities during the class period to seek lead plaintiff status [1] - The lead plaintiff represents the interests of all class members and can select a law firm for litigation [1] - Participation as a lead plaintiff does not affect an investor's ability to share in any potential recovery [1] About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [1] - The firm has a strong track record, recovering $8.4 billion for investors over the past five years [1]

Core Viewpoint - The Federal Energy Regulatory Commission (FERC) has authorized the acquisition of TXNM Energy by Blackstone Infrastructure, determining that the transaction aligns with public interest and does not negatively impact competition or rates [1]. Regulatory Approvals - FERC's order indicates no evidence that state or federal regulations will be impaired by the acquisition [1] - The acquisition has received approval from the Federal Communications Commission (FCC) and the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired [1] - The Public Utility Commission of Texas (PUCT) approved a settlement for the acquisition earlier this month [1] Shareholder Support - TXNM Energy shareholders overwhelmingly approved the merger in August 2025 [1] Company Background - TXNM Energy, based in Albuquerque, New Mexico, serves over 800,000 homes and businesses in Texas and New Mexico through its regulated utilities, TNMP and PNM [1]

Current Reports on Form 8-K and other filings with the U.S. Securities and Exchange Commission, which are available at [www.sec.gov].All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this press release is ...

Kootenay Silver Enters into Marketing Agreement with Gold Standard Media, LLC [Accessibility Statement] Skip NavigationVANCOUVER, BC, Feb. 20, 2026 /PRNewswire/ - Kootenay Silver Inc. (TSXV: KTN) (OTCQX: KOOYF) (the "Company" or "Kootenay") is pleased to announce it has entered into a marketing services agreement (the "Marketing Agreement") with Gold Standard Media, LLC ("Gold Standard"), an internet marketing and advertising company. Gold Standard, together with certain Affiliates (as such term is defined ...

Summit Hotel Properties Announces 2026 Annual Meeting of Stockholders [Accessibility Statement] Skip NavigationAUSTIN, Texas, Feb. 20, 2026 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that its 2026 Annual Meeting of Stockholders will be held Wednesday, May 20, 2026, beginning at 8:00 a.m. Central Time. The meeting will be held at the Hampton Inn & Suites Austin Downtown located at 200 San Jacinto Boulevard, Austin, Texas 78701. The meeting is open to all stockho ...